Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients
By: Yang Wang, Lei Wang, Xingwang Li, Baocheng Liu, Qingzhu Zhao, Peng Chen, Ti Wang, Tao Li, Jue Ji, Fengping Yang, Quan Wang, Jinfen Wang, Yanzeng Xiao, Yifeng Xu, Guoyin Feng, Zhihai Peng, Lin He and Guang He

BMC Cancer 2010, 10:523 doi:10.1186/1471-2407-10-523
Published: 4 October 2010

Abstract (Provisional)

Background

Genetic factors related to the regulation of apoptosis in schizophrenia patients may be involved in a reduced vulnerability to cancer. XRCC4 is one of the potential candidate genes associated with schizophrenia which might induce colorectal cancer resistance.

Methods

To examine the genetic association between colorectal cancer and schizophrenia, we analyzed five SNPs (rs6452526, rs2662238, rs963248, rs35268, rs2386275) covering ~205.7 kb in the region of XRCC4.

Results

We observed that two of the five genetic polymorphisms showed statistically significant differences between 312 colorectal cancer subjects without schizophrenia and 270 schizophrenia subjects (rs6452536, p = 0.004, OR 0.61, 95% CI 0.44-0.86; rs35268, p = 0.028, OR 1.54, 95% CI 1.05-2.26). Moreover, the haplotype which combined all five markers was the most significant, giving a global p = 0.0005.

Conclusions

Our data firstly indicate that XRCC4 may be a potential protective gene towards schizophrenia, conferring reduced susceptibility to colorectal cancer in the Han Chinese population.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements